Every recall we track for Regeneron Pharmaceuticals Inc — 3 in all — plus the complaints and injury reports the public filed about them.
Regeneron recalls Libtayo (cemiplimab-rwlc) injections due to lack of sterility assurance. This could lead to infections if used improperly. Affected units have specific lot numbers and expiration dates.
Regeneron recalls EYLEA (aflibercept) injections due to reported syringe breakage. Affected lots expire by January 2025. Patients should contact the manufacturer for details.
Regeneron recalls EYLEA injections due to reported syringe breakage. Affected lots expire 10/31/24 or 1/30/25. Stop using if you have the specific lot numbers listed.
